| 1 |
-
Retrospective study evaluating association of colorectal tumors and hepatitis C virus
-
8/29/2024 7:51:40 AM | Browse: 128 | Download: 530
|
| 2 |
-
Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance
-
8/3/2023 10:22:43 AM | Browse: 275 | Download: 1084
|
| 3 |
-
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
-
6/28/2023 7:41:04 AM | Browse: 327 | Download: 1162
|
| 4 |
-
Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report
-
5/16/2023 7:16:46 AM | Browse: 315 | Download: 996
|
| 5 |
-
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
-
4/7/2023 5:51:03 AM | Browse: 334 | Download: 1052
|
| 6 |
-
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
-
12/2/2022 9:49:51 AM | Browse: 500 | Download: 1276
|
| 7 |
-
Milestones in the discovery of hepatitis C
-
9/29/2022 10:42:42 AM | Browse: 648 | Download: 1657
|
| 8 |
-
Missed opportunities for hepatitis C treatment at a tertiary care hospital in South Australia
-
8/26/2022 9:51:35 AM | Browse: 464 | Download: 1126
|
| 9 |
-
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
-
6/23/2022 2:39:01 PM | Browse: 585 | Download: 1598
|
| 10 |
-
Impact of utilization of hepatitis C positive organs in liver transplant: Analysis of united network for organ sharing database
-
5/24/2022 10:35:19 AM | Browse: 1201 | Download: 1194
|
| 11 |
-
Viral hepatitis: Past, present, and future
-
4/6/2022 8:50:05 AM | Browse: 568 | Download: 1081
|
| 12 |
-
Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report
-
2/22/2022 9:25:38 AM | Browse: 469 | Download: 1394
|
| 13 |
-
Viral hepatitis in 2021: The challenges remaining and how we should tackle them
-
12/31/2021 12:21:18 PM | Browse: 555 | Download: 981
|
| 14 |
-
Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
-
11/24/2021 9:54:22 AM | Browse: 524 | Download: 1776
|
| 15 |
-
Management of hepatitis B and C in special population
-
10/27/2021 7:14:11 AM | Browse: 676 | Download: 1436
|
| 16 |
-
Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality
-
10/15/2021 9:45:09 AM | Browse: 815 | Download: 1686
|
| 17 |
-
Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease
-
8/4/2021 7:56:20 AM | Browse: 591 | Download: 1138
|
| 18 |
-
Viral hepatitis: Milestones, unresolved issues, and future goals
-
7/26/2021 11:20:59 AM | Browse: 681 | Download: 1485
|
| 19 |
-
Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination
-
7/12/2021 12:42:13 AM | Browse: 774 | Download: 1494
|
| 20 |
-
Breakthroughs and challenges in the management of pediatric viral hepatitis
-
5/20/2021 8:38:05 AM | Browse: 619 | Download: 1441
|
| 21 |
-
Immune disorders and rheumatologic manifestations of viral hepatitis
-
5/10/2021 7:46:10 AM | Browse: 590 | Download: 1616
|
| 22 |
-
From hepatitis A to E: A critical review of viral hepatitis
-
4/21/2021 5:56:26 AM | Browse: 654 | Download: 1391
|
| 23 |
-
Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
-
4/16/2021 10:13:42 AM | Browse: 629 | Download: 1655
|
| 24 |
-
Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection
-
1/26/2021 4:22:54 PM | Browse: 702 | Download: 1942
|
| 25 |
-
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
-
12/18/2020 5:58:43 AM | Browse: 744 | Download: 1572
|
| 26 |
-
Emergency department targeted screening for hepatitis C does not improve linkage to care
-
8/28/2020 3:06:40 PM | Browse: 838 | Download: 2533
|
| 27 |
-
Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population
-
5/27/2020 1:40:57 PM | Browse: 885 | Download: 1945
|
| 28 |
-
Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4
-
1/13/2020 11:27:12 AM | Browse: 951 | Download: 1728
|
| 29 |
-
Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
-
12/20/2019 10:20:31 AM | Browse: 913 | Download: 1626
|
| 30 |
-
Real life efficacy and safety of direct-acting antiviral therapy for treatment of hepatitis C-infected patients with genotypes 1, 2 and 3 in northwest China
-
11/28/2019 10:38:52 AM | Browse: 1171 | Download: 2933
|
| 31 |
-
Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China
-
5/27/2019 8:24:36 AM | Browse: 1098 | Download: 2095
|
| 32 |
-
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
-
5/6/2019 10:43:10 AM | Browse: 1126 | Download: 2130
|
| 33 |
-
Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
-
4/26/2019 3:40:00 AM | Browse: 1179 | Download: 2143
|
| 34 |
-
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
-
3/27/2019 10:37:20 AM | Browse: 1294 | Download: 2542
|
| 35 |
-
Comprehensive analysis of HFE gene in hereditary hemochromatosis and in diseases associated with acquired iron overload
-
2/26/2019 11:29:05 AM | Browse: 1138 | Download: 2601
|
| 36 |
-
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
-
1/27/2019 7:04:05 AM | Browse: 1254 | Download: 1716
|
| 37 |
-
Comparison of hepatitis C virus testing recommendations in high-income countries
-
10/27/2018 4:40:10 AM | Browse: 1140 | Download: 1886
|
| 38 |
-
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
-
10/27/2018 4:40:10 AM | Browse: 1169 | Download: 2487
|
| 39 |
-
European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
-
10/27/2018 4:40:10 AM | Browse: 1046 | Download: 1759
|
| 40 |
-
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
-
10/12/2018 5:32:21 AM | Browse: 1093 | Download: 2141
|
| 41 |
-
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
-
9/27/2018 9:38:46 AM | Browse: 1162 | Download: 1743
|
| 42 |
-
Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
-
9/7/2018 6:15:25 AM | Browse: 1101 | Download: 1459
|
| 43 |
-
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
-
7/27/2018 6:43:44 AM | Browse: 1196 | Download: 2259
|
| 44 |
-
Systematic overview of hepatitis C infection in the Middle East and North Africa
-
7/19/2018 7:04:34 AM | Browse: 1505 | Download: 2293
|
| 45 |
-
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
-
3/16/2018 12:27:25 PM | Browse: 1432 | Download: 2508
|
| 46 |
-
Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey
-
3/16/2018 12:27:25 PM | Browse: 1190 | Download: 2477
|
| 47 |
-
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
-
3/4/2018 12:36:47 PM | Browse: 1008 | Download: 1730
|
| 48 |
-
Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort
-
2/9/2018 7:24:30 AM | Browse: 1620 | Download: 2394
|
| 49 |
-
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
-
1/26/2018 8:09:36 AM | Browse: 1207 | Download: 2302
|
| 50 |
-
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
-
12/27/2017 10:31:19 AM | Browse: 1234 | Download: 2325
|
